These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32287445)

  • 1. Ritter reaction-mediated syntheses of 2-oxaadamantan-5-amine, a novel amantadine analog.
    Leiva R; Gazzarrini S; Esplugas R; Moroni A; Naesens L; Sureda FX; Vázquez S
    Tetrahedron Lett; 2015 Mar; 56(10):1272-1275. PubMed ID: 32287445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel benzopolycyclic amines with NMDA receptor antagonist activity.
    Valverde E; Sureda FX; Vázquez S
    Bioorg Med Chem; 2014 May; 22(9):2678-83. PubMed ID: 24698811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
    Jalily PH; Eldstrom J; Miller SC; Kwan DC; Tai SS; Chou D; Niikura M; Tietjen I; Fedida D
    Mol Pharmacol; 2016 Aug; 90(2):80-95. PubMed ID: 27193582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Anti-influenza A Virus Activity of 2,2-Dialkylamantadines and Related Compounds.
    Torres E; Fernández R; Miquet S; Font-Bardia M; Vanderlinden E; Naesens L; Vázquez S
    ACS Med Chem Lett; 2012 Dec; 3(12):1065-9. PubMed ID: 24900429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different modes of inhibition by adamantane amine derivatives and natural polyamines of the functionally reconstituted influenza virus M2 proton channel protein.
    Lin TI; Heider H; Schroeder C
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():767-74. PubMed ID: 9129648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to overcome resistance of influenza A viruses against adamantane derivatives.
    Scholtissek C; Quack G; Klenk HD; Webster RG
    Antiviral Res; 1998 Feb; 37(2):83-95. PubMed ID: 9588841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.
    Takeda M; Pekosz A; Shuck K; Pinto LH; Lamb RA
    J Virol; 2002 Feb; 76(3):1391-9. PubMed ID: 11773413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of amantadine (1-aminoadamantane) and remantadine (alpha-methyl-1-adamantane methyl amine) hydrochlorides on formation of influenza A viral proteins].
    Galegov GA; Vladyko AS; Linitskaia GL; Shobukhov VM
    Vopr Med Khim; 1981; 27(2):251-4. PubMed ID: 7281566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
    Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W
    Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 3-(2-adamantyl)pyrrolidines with potent activity against influenza A virus-identification of aminoadamantane derivatives bearing two pharmacophoric amine groups.
    Stamatiou G; Kolocouris A; Kolocouris N; Fytas G; Foscolos GB; Neyts J; De Clercq E
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2137-42. PubMed ID: 11514155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine.
    Parsons CG; Panchenko VA; Pinchenko VO; Tsyndrenko AY; Krishtal OA
    Eur J Neurosci; 1996 Mar; 8(3):446-54. PubMed ID: 8963435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance-Mutation (N31) Effects on Drug Orientation and Channel Hydration in Amantadine-Bound Influenza A M2.
    Gleed ML; Ioannidis H; Kolocouris A; Busath DD
    J Phys Chem B; 2015 Sep; 119(35):11548-59. PubMed ID: 26268449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why bound amantadine fails to inhibit proton conductance according to simulations of the drug-resistant influenza A M2 (S31N).
    Gleed ML; Busath DD
    J Phys Chem B; 2015 Jan; 119(3):1225-31. PubMed ID: 25426702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.
    Ma C; Zhang J; Wang J
    Mol Pharmacol; 2016 Sep; 90(3):188-98. PubMed ID: 27385729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Perturbation Effects Exerted by the Influenza A M2 WT Protein Inhibitors Amantadine and the Spiro[pyrrolidine-2,2'-adamantane] Variant AK13 to Membrane Bilayers Studied Using Biophysical Experiments and Molecular Dynamics Simulations.
    Konstantinidi A; Naziris N; Chountoulesi M; Kiriakidi S; Sartori B; Kolokouris D; Amentisch H; Mali G; Ntountaniotis D; Demetzos C; Mavromoustakos T; Kolocouris A
    J Phys Chem B; 2018 Nov; 122(43):9877-9895. PubMed ID: 30285441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic brain concentration of the NMDA receptor antagonist amantadine.
    Kornhuber J; Quack G; Danysz W; Jellinger K; Danielczyk W; Gsell W; Riederer P
    Neuropharmacology; 1995 Jul; 34(7):713-21. PubMed ID: 8532138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of amantadine and rimantadine as anti-influenza-A agents: memorandum from a WHO meeting.
    Bull World Health Organ; 1985; 63(1):51-6. PubMed ID: 3872736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.